Stylage Bi-Soft XXL (2 × 1 mL) is a high-volume hyaluronic acid dermal filler developed for deep volumization, facial contouring, and restoration of significant volume loss.
It is commonly used in areas requiring strong lift and projection, such as the cheeks, chin, jawline, and other facial zones where structural support is essential.
The formulation is designed to provide a balance of firmness and smooth integration, allowing predictable shaping while maintaining natural tissue adaptation.
Clinical results typically last up to 12 months, depending on injection depth, technique, and individual metabolic factors.
Rheological properties / Product data
HA concentration: 21 mg/ml
Technology: IPN-like cross-linking
Elasticity (G’): High
Cohesivity: Medium–high
Texture: Firm, smooth HA gel
Lidocaine content: None
Packaging: 2 syringes × 1 ml
The gel is formulated to deliver stable volume and lift while integrating evenly within deeper tissue planes.
Injection depth & tools
Recommended depth: Deep dermis to subcutaneous
Injection techniques: Bolus, linear threading, fanning
Recommended instruments: Needle or cannula depending on indication
Inject slowly under aseptic conditions and aspirate when clinically appropriate to reduce vascular risk.
Storage & handling
Store at room temperature (do not freeze)
Protect from direct sunlight
Single-use only — use immediately after opening
Do not use if packaging is damaged or expired
Dispose of syringes and needles according to medical waste regulations
For use by licensed medical professionals only. Not intended for self-injection.
Bolus or linear threads in deeper planes as indicated; slow injection with aspiration per best practice.
Common: redness, swelling, bruising, tenderness. Rare but serious: vascular occlusion (blanching, severe pain, visual changes—urgent care required).
Cross‑linked HA restores volume and contour; integrates with surrounding tissue.
Avoid alcohol 24h before and after treatment—vasodilation increases bleeding/bruising and may slow recovery.
Not recommended in pregnancy—elective injectables lack robust safety data; defer until after delivery.
Not advised during breastfeeding—limited data on transfer via milk and infant safety; postpone elective procedures.
